Kim Hamilton

Kim Hamilton serves as the Executive Director of US & Global Commercial Communications at Organon, leading the communications strategy for a diverse product portfolio that includes women's health, biosimilars, cardiovascular and respiratory diseases, and pain management. Previously, Kim held the role of Executive Director of Global Communications at Merck, where responsibilities included corporate narrative development and reputation management across key therapeutic areas such as oncology and HIV. Kim's extensive experience encompasses various strategic communication roles in the pharmaceutical and healthcare sectors, with a proven track record in stakeholder engagement, product launches, and media relations. Kim holds a Bachelor of Arts in Communications from Penn State University.